Cargando…
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Terms of Major Cardiovascular Disease Outcomes in Elderly Patients: A Nationwide Population-Based Cohort Study
Renin and aldosterone activity levels are low in elderly patients, raising concerns about the benefits and risks of angiotensin-converting-enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARB) use. However, data from direct comparisons of the effects of ACEIs on ARBs in the elderly po...
Autores principales: | Chien, Shu-Chen, Ou, Shuo-Ming, Shih, Chia-Jen, Chao, Pei-Wen, Li, Szu-Yuan, Lee, Yi-Jung, Kuo, Shu-Chen, Wang, Shuu-Jiun, Chen, Tzeng-Ji, Tarng, Der-Cherng, Chu, Hsi, Chen, Yung-Tai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985382/ https://www.ncbi.nlm.nih.gov/pubmed/26512568 http://dx.doi.org/10.1097/MD.0000000000001751 |
Ejemplares similares
-
Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade
por: Lin, Chih-Ching, et al.
Publicado: (2017) -
Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study
por: Hsieh, Yu-Cheng, et al.
Publicado: (2016) -
Comprehensive comparison between geriatric and nongeriatric patients with trauma
por: Lin, Pei-Chen, et al.
Publicado: (2022) -
Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Liu, Chia-Lin, et al.
Publicado: (2013) -
Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan
por: Huang, Shiou-Huei, et al.
Publicado: (2012)